ICAD (Intracranial Atherosclerotic Disease) Pathology Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

ICAD (Intracranial Atherosclerotic Disease) Pathology Market is forecasted to value over USD 274 million by 2028 end and register a CAGR of 8% from the forecast period 2022-2028.

Intracranial atherosclerosis (ICAD) is the most common cause of stroke worldwide. This is a progressive narrowing of the cerebral arteries within the skull (intracranial). A stroke can result from a blood clot or from bleeding (hemorrhage) that takes oxygen away from brain cells and causes death. For intracranial atherosclerosis, it has been found that it can start at an early age and progress slowly. Symptoms may not occur until arteries narrow enough to reduce blood flow to the brain. Because the disease often progresses unnoticed, the first symptoms may occur while blood flow to the brain is temporarily blocked.

Market Segments

By product

• Stent
• PTA Balloon

By end users

• Hospital
• Clinic
• Other

Key Players

• Stryker
• Balt
• TERUMO
• MicroPort
• Acandis

Scope of the Report

The research study analyzes the global ICAD (Intracranial Atherosclerotic Disease) Pathology industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by ICAD (Intracranial Atherosclerotic Disease) Pathology Market Report

1. What was the ICAD (Intracranial Atherosclerotic Disease) Pathology Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of the ICAD (Intracranial Atherosclerotic Disease) Pathology Market during the forecast period (2022-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the ICAD (Intracranial Atherosclerotic Disease) Pathology Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.